In glioma, PDE4C suppressed migration and induced apoptosis through the cAMP-p53 axis, and its expression could be epigenetically silenced by promoter hypermethylation, suggesting a role as a glioma biomarker (40). This evidence concerns the gene PDE4C and central nervous system cancer.